August 29, 2025

Gastrointestinal Foreign Bodies: When to Use Computed Tomography Versus Radiograph

A physician-focused review of gastrointestinal foreign body ingestion is looking to guide triage and intervention.

Conexiant

August 28, 2025

First Generic GLP-1 for Weight Loss Approved

FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning.

Conexiant

August 28, 2025

CD68/CD163 Mark Worse Outcomes in Skeletal Hodgkin Lymphoma, Study

Skeletal classic Hodgkin lymphoma shows a macrophage-rich, B-cell–poor microenvironment, with high CD68/CD163 linked to worse survival.

Conexiant

August 22, 2025

Linear Hyperpigmentation After Chemotherapy: What's Your Diagnosis?

A 15-year-old girl developed distinctive, painless, whip-like streaks across her trunk and back after receiving combination chemotherapy for ovarian yolk sac tumor. What’s your diagnosis?

Conexiant

August 19, 2025

Biopsy Strategies to Improve Granuloma Detection in Crohn’s Disease

Researchers link biopsy size, number, lesion severity, and location to granuloma detection in Crohn’s disease.

Conexiant

August 19, 2025

Mortality and Readmission Rates With Lactated Ringer’s and Saline in Hospital Trial

Outcomes at 90 days showed no substantial differences in mortality or readmission, though researchers say small differences could be clinically relevant.

Conexiant

August 15, 2025

Indocyanine Green Angiography Shows Potential in Leak Prevention

The benefit might be in preventing grade A or B leaks, the researchers posited.

Conexiant

August 15, 2025

Trial Tests Timing of IOPTH in RHPT Surgery

About 15% of patients with parathyroid gland enlargement from chronic kidney disease still require surgery within 10 years of starting dialysis, even with calcimimetics treatment. Surgical failure rates can reach 28%, often due to missed ectopic or supernumerary glands.

Conexiant

August 14, 2025

Tumor Budding May Predict Survival in Head and Neck Cancer

Tumor budding emerges as a practical histologic marker, as clinicians seek low-cost predictors of occult metastasis in surgically treated patients.

Conexiant